Disease Markers

Disease Markers / 2010 / Article

Open Access

Volume 28 |Article ID 918457 | https://doi.org/10.3233/DMA-2010-0719

Houda Bouanene, Abdelhédi Miled, "Conflicting Views on the Molecular Structure of the Cancer Antigen CA125/MUC16", Disease Markers, vol. 28, Article ID 918457, 10 pages, 2010. https://doi.org/10.3233/DMA-2010-0719

Conflicting Views on the Molecular Structure of the Cancer Antigen CA125/MUC16

Received16 Jul 2010
Accepted16 Jul 2010


CA125 is a tumor antigen used to monitor the progression and regression of epithelial ovarian cancer. Despite the widespread use of CA125, the biochemical and molecular nature of this antigen is poorly understood. Analysis of the structure of CA125 is essential for determining the physiological role of this very significant tumor marker. Accumulated experimental evidence has shown that CA125 epitopes reside on a molecule of very complex architecture in terms of both protein backbone and oligosaccharide structures. It is not clear whether the heterogeneity of CA125 molecular characteristics are due to the variability of biological sources from which the molecule was isolated or to the different biophysical methods used for the characterization of all the oligosaccharides linked to CA125 or to the presence of glycoisoforms for this protein. This review attempts to summarize emerging data related to molecular characteristics of CA125 and to compare approaches undertaken to reach a better understanding of molecular features of this tumor marker.

Copyright © 2010 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Order printed copiesOrder